Western blotting revealed that PAH treatment significantly decreased intracellular levels of GPX4 and SLC7A11, while increasing protein expression of transferrin receptor (TFRC), ferritin heavy chain (FTH1), and ferritin light chain (FTL). This evidence concerns the gene FTL and pulmonary arterial hypertension.